Production (Stage)
Turnstone Biologics Corp.
TSBX
$0.3329
-$0.0065-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.81M | -12.87M | -17.03M | -21.30M | -19.63M |
| Total Depreciation and Amortization | 301.00K | 337.00K | 491.00K | 498.00K | 509.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.65M | 352.00K | 377.00K | 500.00K | 288.00K |
| Change in Net Operating Assets | 1.76M | -4.29M | -1.41M | 4.38M | 1.37M |
| Cash from Operations | -7.09M | -16.48M | -17.58M | -15.93M | -17.46M |
| Capital Expenditure | -- | 19.00K | 1.00K | -105.00K | -144.00K |
| Sale of Property, Plant, and Equipment | 12.00K | 0.00 | 0.00 | 25.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 21.25M | 24.25M | 19.02M | 14.24M |
| Cash from Investing | 12.00K | 21.27M | 24.25M | 18.94M | 14.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 44.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 59.00K | -92.00K | -- |
| Cash from Financing | -- | 0.00 | 59.00K | -48.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.08M | 4.79M | 6.73M | 2.97M | -3.37M |